Overview

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109

Status:
Suspended

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

The purpose of this study is to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Administered in Multi Intramuscular Doses to Healthy Subjects.

Phase:

Phase 2

Details

Lead Sponsor:

Green Cross Corporation

Collaborator:

Korean Center for Disease Control and Prevention

Treatments:

Aluminum Hydroxide
Vaccines